Paliris La 50MG Pfs

Composition

Paliperidone palmitate 50 mg/0.5 mL (long-acting injectable suspension)

Uses of Paliris La 50MG Pfs

Treatment of schizophrenia in adults; may be used for maintenance therapy with a long-acting antipsychotic as prescribed.

• •Controls symptoms of schizophrenia
• •Helps prevent relapse with monthly/LA dosing
• •Improves adherence vs daily tablets
• •Reduces hallucinations and delusions
• •Stabilizes mood and behavior

How it works

Paliperidone is an atypical antipsychotic that mainly blocks dopamine (D2) and serotonin (5‑HT2A) receptors, helping reduce psychotic symptoms. The palmitate ester is a long‑acting depot form that slowly releases paliperidone after intramuscular injection for sustained effect.

Directions for use

Prescription-only long-acting injection. Administer as an intramuscular injection by a healthcare professional (deltoid or gluteal muscle as advised). Follow the exact dosing schedule set by the psychiatrist; do not self-inject, shake, or mix unless instructed in the product leaflet.

Side effects

Common side effects of Paliris La 50MG Pfs may include:

• •Injection site pain
• •sleepiness/sedation
• •dizziness
• •headache